A patient has died while taking a closely watched gene therapy for muscular dystrophy. Sarepta Therapeutics announced the death Tuesday morning, sending the company's shares plummeting in morning ...

Changsheng Wu (53), has been appointed Executive Vice President, Procurement and member of the Global Executive Team at Huhtamaki, effective April 1, 2025. He will report to President and CEO Ralf K.